why choose us

First received: November 12, 2024

Clinical Trial: Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Social Anxiety Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase 2a, Exploratory, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability, and Efficacy of EMP-01 in Adult Participants With Social Anxiety Disorder

Brief Summary: This Phase 2 study (protocol number EMP-01-201) will determine the safety and tolerability of a short-term treatment with an oral dosage form of EMP-01 in adult participants with social anxiety disorder (SAD) and will assess exploratory efficacy of repeated doses of EMP-01 versus placebo.

Read more